Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Dr. Sergey Tsukanov, PhD
Senior Director Chemistry at Eli Lilly and Company
Speaker

Profile

Sergey Tsukanov is Senior Director in Synthetic Molecule Design and Development group at Eli Lilly and Company. Sergey has studied chemistry at North Carolina State University. After obtaining his Ph.D. he conducted his postdoctoral training at Vanderbilt University and joined Eli Lilly in 2013 as a part of LIFA Innovation Fellowship program. For over ten years with Eli Lilly Sergey has supported CMC efforts across various Peptide and Oligonucleotide programs and in his current role Sergey is focused on late-stage development and commercialization activities for Oligonucleotide drug candidates.

Agenda Sessions

  • Making Oligonucleotides a High-Volume Reality: Next-Gen Platforms and Strategy for Oligonucleotide Manufacturing

    13:15